Children’s Tumor Foundation
-
Neurofibromin fine-tunes bone growth
The protein neurofibromin acts as a brake in a signaling pathway that is important in bone development, Vanderbilt researchers have discovered. Read MoreMay 6, 2015
-
Novel treatment strengthens bones in genetic disease
An enzyme therapy may prevent skeletal abnormalities associated with the genetic disorder neurofibromatosis type-1, Vanderbilt investigators have discovered. Read MoreAug 7, 2014
-
Skeletal defects in genetic disorder
A new mouse model provides a tool for testing novel therapeutic approaches for neurofibromatosis. Read MoreNov 18, 2011